ADAM17 and cancer: Since chronic inflammation is one of highest risk factors for developing CRC, further studies investigating the role of ADAM17 downregulation in intestinal regeneration and chronic inflammation, utilizing suitable animal models and more physiological experimental approaches, might shed more light on the complex role of ADAM17 in cancer pathology.